N -Myristoyltransferase Inhibitors as a Potential Starting Point for the Development of Antischistosomal Agents
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
High Resolution Image Download MS PowerPoint Slide Schistosomiasis remains a major global health challenge, and the threat of emerging praziquantel resistance highlights the need for new therapeutic strategies. Here, the Schistosoma mansoni N -myristoyltransferase was evaluated as a potential drug target. Six reported NMT inhibitors were tested for Sm NMT inhibition and binding, with two compounds showing low nanomolar potency. These also inhibited NMT of S. hematobium and S. japonicum, and exhibit favorable drug-like physicochemical properties. In addition, antiparasitic activity against newly transformed schistosomula and adult worms was investigated. The results confirm NMT as a viable target for drug discovery against schistosomiasis and provide a basis for further optimizations of Sm NMT inhibitors.
Fields of Study & Subjects
Parasites and Host Interactions
Trypanosoma species research and implications
Helminth infection and control
Publication details
- Journal / source
- ACS Medicinal Chemistry Letters
- Volume
- 17
- Issue
- 4
- Pages
- 945–951
- Publication date
- 30 March 2026
- Language
- EN